Relevant conflicts of interest/financial disclosures: Nothing to report.
Letters: New Observations
Leukodystrophies in idiopathic adult-onset ataxia: Frequency and phenotype in 105 patients
Article first published online: 7 AUG 2013
© 2013 Movement Disorder Society
Volume 28, Issue 14, pages 2033–2035, December 2013
How to Cite
Müller vom Hagen, J., Synofzik, M., Schicks, J., Krägeloh-Mann, I. and Schöls, L. (2013), Leukodystrophies in idiopathic adult-onset ataxia: Frequency and phenotype in 105 patients. Mov. Disord., 28: 2033–2035. doi: 10.1002/mds.25617
Full financial disclosures and author roles may be found in the online version of this article.
Dr. J. Müller vom Hagen received a travel grant by Actelion Pharmaceuticals.
Dr. Synofzik received a research grant by the Volkswagen Foundation, a travel grant by the Movement Disorders Society, and honoria from Fresenius Kabi and Actelion Pharmaceuticals.
Dr. Schicks received a travel grant by the Movement Disorder Society and a research grant by the fortune-Programm, University of Tuebingen (1890-0-0).
Dr. Schöls received research grants of the Deutsche Forschungsgemeinschaft (SCHO754/4-1 and SCHO754/5-1), grants of the German Research Council (BMBF) to Leukonet (01GM0644) and mitoNET (01GM0864) and E-RARE grants to EUROSPA (01GM0807) and RISCA (01GM0820). He further received funding from the HSP-Selbsthilfegruppe Deutschland eV.
Dr. Krägeloh-Mann was member of the scientific board of the biopharmaceutical company ZYMENEX for a clinical trial I/II-study for enzyme replacement in MLD in 2007; and is currently member of the scientific board of the biopharmaceutical company SHIRE for a world-wide clinical trial I/II-study for intrathecal enzyme replacement in MLD. This did not imply any involvement, nor funding in the present study.
- Issue published online: 9 DEC 2013
- Article first published online: 7 AUG 2013
- Manuscript Accepted: 6 JUN 2013
- Manuscript Revised: 14 MAY 2013
- Manuscript Received: 12 MAR 2013
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions and you will be able to log in to access content. Some users may also log in directly via OpenAthens.
Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.